Fewer Doctors Screening Older Men for Prostate Cancer, Study Finds
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
Despite the controversy regarding whether most men should be screened for prostate cancer, many doctors appear to agree that older men do not need to be screened, a new study suggests.
Between 2007 and 2009, the rate of early stage prostate cancer among men ages 75 and older decreased by 25 percent, the study found.
The decrease occurred shortly after an influential organization, known as the U.S. Services Preventive Task Force, recommended against screening men of this age group for the disease.
The findings suggest the recommendations led to a decline in prostate cancer screening rates among older men, which in turn, led to a decrease in the number of prostate cancer cases found in this group, the researchers said.
In 2011, the task force also recommended not to screen younger men for prostate cancer unless they were at high-risk for the disease, such as those men with relatives who developed cancer at a young age.
Given that the potential harms of screening — which include false alarms, increased worry and treatment for side effects, such as erectile dysfunction — outweigh the benefits, "we hope to see a similar decrease in early prostate cancer incidence in young men," Dr. Mitchell Katz, deputy editor of the journal Archives of Internal Medicine, in which the study appears, wrote in an editorial accompanying the study.
The findings are based on information from more than 254,000 prostate cancer cases in the United States.
Get the world’s most fascinating discoveries delivered straight to your inbox.
While the rate of prostate cancer declined among all men ages 30 to 74 between 2007 and 2009, the decrease was smaller for men younger than 75. The rate dropped by 15 percent among men ages 65 to 74, and 11 percent among men ages 30 to 64.
Many experts believe a practice known as active surveillance could reduce the harms of prostate cancer screening. Under active surveillance, patients with low-risk prostate cancer receive regular follow-up testing, and are treated only if their cancer becomes more aggressive.
The new study, conducted by David Howard of Emory University in Atlanta, is published today (July 23) in the journal Archives of Internal Medicine.
Pass it on: Prostate cancer screening in men ages 75 and older appears to have declined.
Follow MyHealthNewsDaily on Twitter @MyHealth_MHND. We're also on Facebook & Google+.

